Evaluating the in-vivo effects of methanolic extract of a. boonei on liver enzyme function in alloxan induced diabetes mellitus.
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of Study
- 1.3Problem Statement
- 1.4Objective of Study
- 1.5Limitation of Study
- 1.6Scope of Study
- 1.7Significance of Study
- 1.8Structure of the Research
- 1.9Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Overview of Liver Enzyme Function
- 2.2Diabetes Mellitus and Its Impact on Liver Enzymes
- 2.3A. boonei: Botanical Description and Medicinal Uses
- 2.4Previous Studies on A. boonei Extracts
- 2.5In-vivo Studies on Herbal Extracts and Liver Enzymes
- 2.6Mechanisms of Action of Herbal Extracts on Liver Enzymes
- 2.7Factors Affecting Liver Enzyme Function
- 2.8Liver Enzyme Biomarkers in Health and Disease
- 2.9Methodologies for Evaluating Liver Enzyme Function
- 2.10Summary of Literature Review
Chapter THREE
SYSTEM DESIGN AND IMPLEMENTATION
- 3.1Research Design and Rationale
- 3.2Sampling Methods and Participants
- 3.3Data Collection Techniques
- 3.4Variables and Measurements
- 3.5Data Analysis Procedures
- 3.6Ethical Considerations
- 3.7Quality Assurance Measures
- 3.8Statistical Tools and Software
Chapter FOUR
SYSTEM TESTING AND EVALUATION
- 4.1Characteristics of Study Participants
- 4.2Baseline Liver Enzyme Levels
- 4.3Effects of A. boonei Extract on Liver Enzymes
- 4.4Comparison with Standard Diabetes Treatment
- 4.5Influence of Dosage and Duration on Liver Enzyme Function
- 4.6Adverse Effects and Safety Profile
- 4.7Interpretation of Findings
- 4.8Implications for Clinical Practice
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- 5.1Summary of Findings
- 5.2Conclusion
- 5.3Recommendations for Future Research
- 5.4Practical Applications
- 5.5Contribution to Knowledge
Thesis Abstract
Abstract
Diabetes mellitus is a metabolic disorder characterized by hyperglycemia and altered lipid metabolism, leading to various complications including liver dysfunction. Alloxan is a diabetogenic agent commonly used to induce diabetes in experimental animals. Studies have shown that Alloxan induces oxidative stress and impairs liver function by disrupting the activities of key enzymes involved in glucose and lipid metabolism. In this study, the in-vivo effects of the methanolic extract of A. boonei on liver enzyme function in Alloxan-induced diabetes mellitus were evaluated. A. boonei, also known as Ata-mangrove, is a plant with known traditional medicinal properties, including antidiabetic and antioxidant effects. The aim of this research was to investigate the potential hepatoprotective effects of A. boonei in the context of diabetes-induced liver damage. Male Wistar rats were divided into five groups Group I (control), Group II (diabetic control), Group III (diabetic rats treated with metformin), Group IV (diabetic rats treated with low dose of A. boonei extract), and Group V (diabetic rats treated with high dose of A. boonei extract). Diabetes was induced in groups II-V using Alloxan, and treatment with metformin or A. boonei extract was administered orally for 28 days. Liver enzyme function was assessed by measuring the activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and total bilirubin levels in serum samples. Additionally, histopathological analysis of liver tissues was performed to evaluate the structural changes. The results demonstrated that Alloxan-induced diabetes led to a significant increase in liver enzyme activities, indicating liver dysfunction. Treatment with A. boonei extract, especially at the high dose, significantly attenuated the elevation of ALT, AST, ALP activities, and total bilirubin levels compared to the diabetic control group. Histopathological examination revealed that A. boonei extract ameliorated liver damage by reducing inflammation and restoring the normal liver architecture. In conclusion, the methanolic extract of A. boonei exhibited hepatoprotective effects in Alloxan-induced diabetic rats by improving liver enzyme function and reducing liver damage. These findings support the traditional use of A. boonei as a potential therapeutic agent for managing diabetes-related liver complications.
Thesis Overview
<p>
</p><p>INTRODUCTION</p><p>1.1Background of Study</p><p>The present decade has witnessed a great and intense resurgence in the interest and use of the plant (Briskin., 2000). The healing power of herbs identified and botanical medicine has been one of the oldest practiced professions by humanity (Oduolaet al ., 2007). In fact, the use of synthetic pharmaceutical products and hepatotoxic agent reported not only to connect or some serious adverse effects but these drugs are costly and not within the reach of all. However, traditional use of herbs to promote healing is not an alien in any continent.</p><p>Diabetes mellitus represents a group of metabolic disorders in which there is an impaired glucose utilization hyperglycaemia which is an increase in the blood glucose level beyond normal values (Hazuda, 1991; Adonu et al., 2013). Diabetes is a chronic disease characterized by elevated blood glucose level and disturbances in carbohydrate, fat and protein metabolism (Sky, 2000; Rother, 2007).</p><p>A. boonei De Wild belongs to the family Apocynaceae. It is a large evergreen tree and is one of the most widely used medicinal plants in Africa and beyond. It is distributed throughout the tropics and the rain forest of west and Central Africa (Oliver-Bever, 1986; Olajide, et al., 2000). It is known by different names in different cultures and tribal settings. The plant parts are claimed to have medicinal properties in some cultures and climes. In the local markets in West and Central Africa, Alstoniaboonei is often among the most common sold plant as crude drugs. Parts of the plant are employed for the treatment of a variety of ailments in Africa and the stem bark has been listed in the Africa Pharmacopoeia as an antimalarial drug (Bello et al ., 2009). Various pharmacological studies have been carried out on this plant products which showed that the extracts possess anti-malaria, antipyretic, analgesic and anti-inflammatory properties (Ojewole, 1984; Olajideet al., 2000), anthelmintic (Wright et al, 1993), diuretic, spasmolytic and hypotensive properties (Iwu, 1993), antifebrile, astringent, (Iwu and Klayman, 1993), Immuno-stimulant property (Taiwo et al, 1998), antipsychotic and anxiolytic effect (Elisabetsky and Costa-campos, 2006), reversible antifertility effect, (Raji et al, 2005), among others..</p><p>1.2.JUSTIFICATION OF STUDY</p><p>Alstoniaboonei, a large evergreen tree belonging to the family Apocynaceae is one of the widely used medicinal plants in Africa and beyond. It is distributed throughout the tropics and the rain forest of west and Central Africa (Oliver-Bever, 1986; Olajide 2000). It is known by different names in different cultures and tribal settings. It is not edible as food but possesses roots, stem barks, leaves, fruits, seeds, flowers, and latex which are claimed to have medicinal properties in some cultures and climes.</p><p>Various documented and undocumented claims have it that alcoholic or aqueous preparations from some parts of the plant especially the stem bark have medicinal uses for treating febrile illness, jaundice, painful micturition, rheumatic conditions (Ojewole, 1984; Asuzu and Onaga, 1991), as an antivenom against snake bite, as antidote against arrow poisoning etc. The extract of the stem bark is commonly used as a febrifuge in treating malaria and is listed in the African pharmacopoeia as an anti-malarial drug (Olajide et al, 2000).</p><p>Currently, there is paucity of information on the hepatic effects of A. boonei on those that it as antidiabetic drug. This study therefore aims at accessing Aspartate aminotransferase (ASP), Alkaline phosphatase (ALP), Alanine aminotransferase (ALT), on alloxan induced diabetic rabbits.</p><p>1.3. AIM</p><p>This study is aimed at evaluating the in-vivo effects of methanolic extract of A. boonei on liver enzyme function in Alloxan induced diabetes mellitus.</p><p>SPECIFIC OBJECTIVES</p><p>Determining of aspartate aminotransferease, alkaline phosphatase, alanine aminotransferase on Alloxan induced male diabetic rabbits .Determining of aspartate aminotransferease, alkaline phosphatasea, alanine aminotransferase on Control</p><p>Correlate the results generated from the study of the two groups</p><p>NULL HYPOTHESIS</p><p>Methanolic extract of Alstoniaboonei stem bark, leaves and root, does not have effect on the liver function in alloxan induced diabetic rabbits</p><p>ALTERNATE HYPOTHESIS</p><p>Methanolic extract of Alstoniabooneileaves, root and stem bark have effect on the liver function of alloxan induced diabetic rabbits</p>
<br><p></p>